BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 28506368)

  • 1. Human Immunodeficiency Virus Infection, Antiretroviral Therapy, and Liver Pathology.
    Sonderup MW; Wainwright HC
    Gastroenterol Clin North Am; 2017 Jun; 46(2):327-343. PubMed ID: 28506368
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Long-term follow-up of patients triply infected with HIV and hepatitis B and C viruses in a comprehensive hospital in central China.
    Yang R; Gui X; Xiong Y; Gao S
    J Viral Hepat; 2017 Dec; 24(12):1192-1193. PubMed ID: 28632964
    [No Abstract]   [Full Text] [Related]  

  • 3. Chronic liver disease in the human immunodeficiency virus patient.
    Acharya C; Dharel N; Sterling RK
    Clin Liver Dis; 2015 Feb; 19(1):1-22. PubMed ID: 25454294
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Human immunodeficiency virus and coinfection with hepatitis B and C.
    Petty LA; Steinbeck JL; Pursell K; Jensen DM
    Infect Dis Clin North Am; 2014 Sep; 28(3):477-99. PubMed ID: 25151567
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Therapeutic interventions for HIV infection and chronic viral hepatitis.
    Cooper CL
    Clin Infect Dis; 2005 Jul; 41 Suppl 1():S69-72. PubMed ID: 16265617
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A clinicopathological cohort study of liver pathology in 301 patients with human immunodeficiency virus/acquired immune deficiency syndrome.
    Sonderup MW; Wainwright H; Hall P; Hairwadzi H; Spearman CW
    Hepatology; 2015 May; 61(5):1721-9. PubMed ID: 25644940
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Hepatotoxicity of coinfected patients].
    Bessone F; Belloso W; Schroder T
    Acta Gastroenterol Latinoam; 2006 Jun; 36 Suppl 1():S43-5; discussion S74-82. PubMed ID: 16862858
    [No Abstract]   [Full Text] [Related]  

  • 8. Liver Disease in Human Immunodeficiency Virus Infection.
    Oikonomou KG; Tsai E; Sarpel D; Dieterich DT
    Clin Liver Dis; 2019 May; 23(2):309-329. PubMed ID: 30947879
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hepatotoxicity of antiretroviral drugs is reduced after successful treatment of chronic hepatitis C in HIV-infected patients.
    Labarga P; Soriano V; Vispo ME; Pinilla J; Martin-Carbonero L; Castellares C; Casado R; Maida I; Garcia-Gasco P; Barreiro P
    J Infect Dis; 2007 Sep; 196(5):670-6. PubMed ID: 17674307
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hepatic safety and HAART.
    McGovern B
    J Int Assoc Physicians AIDS Care (Chic); 2004 Nov; 3 Suppl 2():S24-40. PubMed ID: 15673131
    [No Abstract]   [Full Text] [Related]  

  • 11. Antiretroviral hepatotoxicity in human immunodeficiency virus-infected patients.
    Hernandez LV; Gilson I; Jacobson J; Affi A; Puetz TR; Dindzans VJ
    Aliment Pharmacol Ther; 2001 Oct; 15(10):1627-32. PubMed ID: 11564003
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Liver stiffness values in HIV-infected patients with isolated anti-hepatitis B core antibodies.
    Chakvetadze C; Bani-Sadr F; Lescure FX; Fontaine C; Le Pendeven C; Bonnard P; Mariot P; Soussan P; Pialoux G
    Med Mal Infect; 2013 Jun; 43(6):222-5. PubMed ID: 23597924
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Lopinavir/ritonavir in patients with human immunodeficiency virus infection in special situations].
    Tasias M; Aldeguer JL
    Enferm Infecc Microbiol Clin; 2014 Nov; 32 Suppl 3():18-21. PubMed ID: 25542871
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Elevated liver enzymes in HIV monoinfected patients on HIV therapy: what are the implications?
    Ingiliz P; Benhamou Y
    J HIV Ther; 2009 Mar; 14(1):3-7. PubMed ID: 19731558
    [No Abstract]   [Full Text] [Related]  

  • 15. Antiretroviral Therapies for Human Immunodeficiency Virus and Liver Disease: Challenges and opportunities.
    Abarca JC; Huerta L; Fierro NA
    Ann Hepatol; 2020; 19(2):121-122. PubMed ID: 32138869
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hepatic histopathology and clinical characteristics associated with antiretroviral therapy in HIV patients without viral hepatitis.
    Akhtar MA; Mathieson K; Arey B; Post J; Prevette R; Hillier A; Patel P; Ram LJ; Van Thiel DH; Nadir A
    Eur J Gastroenterol Hepatol; 2008 Dec; 20(12):1194-204. PubMed ID: 18989143
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Outcomes of starting first-line antiretroviral therapy in hepatitis B virus/HIV-coinfected patients in Ghana.
    Chadwick D; Ankcorn M; Sarfo F; Phillips R; Fox Z; Garcia A; Appiah L; Bedu-Addo G; Geretti AM
    J Antimicrob Chemother; 2012 Dec; 67(12):2939-42. PubMed ID: 22915461
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Infections with human immunodeficiency viruses. Part II: Antiretroviral drugs, therapeutic options, and diagnostics].
    Stock I
    Med Monatsschr Pharm; 2011 Jul; 34(7):234-44; quiz 245-6. PubMed ID: 21809598
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Short Communication: Few Liver-Infiltrating Cells Express CXCR3 in HIV/HCV Patients Commencing Antiretroviral Therapy.
    Stephanie M; Susufi YG; Krisnuhoni E; Gani RA; Yunihastuti E; Lee S; Tanaskovic S; Price P
    AIDS Res Hum Retroviruses; 2016 Dec; 32(12):1202-1204. PubMed ID: 27250905
    [TBL] [Abstract][Full Text] [Related]  

  • 20. HIV/HCV co-infection: histopathologic findings, natural history, fibrosis, and impact of antiretroviral treatment: a review article.
    Petrovic LM
    Liver Int; 2007 Jun; 27(5):598-606. PubMed ID: 17498243
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.